Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AD - Alzheimer's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00582855
What this trial is testing

Effect of AQW051 in Patients With Memory Impairment

Who this might be right for
Mild Alzheimer's DiseaseAmnestic Mild Cognitive Impairment
Novartis Pharmaceuticals 54
Early research (Phase 1)Study completedNCT00495417
What this trial is testing

Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Affiris AG 24
Not applicableEnded earlyNCT06217146
What this trial is testing

A Medical Cannabis Oil for Treatment of Agitation and Disruptive Behaviors in Subjects With Dementia.

Who this might be right for
Agitation,PsychomotorDisruptive BehaviorDementia+1 more
M. H MediCane Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT03118947
What this trial is testing

Pimavanserin for the Treatment of Agitation and Aggression in Subjects With Alzheimer's Disease

Who this might be right for
Agitation and Aggression in Alzheimer's Disease
ACADIA Pharmaceuticals Inc. 79
Testing effectiveness (Phase 2)Study completedNCT04070378
What this trial is testing

Study of Daratumumab in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Marc L Gordon, MD 16
Large-scale testing (Phase 3)Study completedNCT00594568
What this trial is testing

Effect of LY450139 on the Long Term Progression of Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 1,537
Early research (Phase 1)Study completedNCT03838185
What this trial is testing

Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses of J147

Who this might be right for
Alzheimer's Disease
Abrexa Pharmaceuticals, Inc. 64
Not applicableStudy completedNCT03422250
What this trial is testing

Non-invasive Stimulation of Brain Networks and Cognition in Alzheimer's Disease and Frontotemporal Dementia

Who this might be right for
Alzheimer's DiseaseFrontotemporal Dementia, Behavioral Variant
IRCCS Centro San Giovanni di Dio Fatebenefratelli 45
Not applicableLooking for participantsNCT07731191
What this trial is testing

Digital Solutions for Predicting the Biological Mechanisms of Alzheimer's Disease Through the Analysis of Risk Factors

Who this might be right for
Mild Cognitive Impairment (MCI)Subjective Cognitive Decline (SCD)
IRCCS Centro San Giovanni di Dio Fatebenefratelli 240
Testing effectiveness (Phase 2)Ended earlyNCT04311515
What this trial is testing

To Evaluate Safety, Tolerability and Pharmacological Effects of PU AD in Subjects With Mild AD Dementia

Who this might be right for
Alzheimer Disease
Samus Therapeutics, Inc. 4
Not applicableStudy completedNCT06275243
What this trial is testing

Polymorphism of ApoE in Alzheimer's Disease: Genetic Study in Castile and Leon (Spain)

Who this might be right for
Alzheimer Disease
Universidad de León 511
Testing effectiveness (Phase 2)Study completedNCT03354143
What this trial is testing

Hypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults (HIPAC Trial)

Who this might be right for
Hypertension
University of Texas Southwestern Medical Center 85
Large-scale testing (Phase 3)Study completedNCT00506415
What this trial is testing

Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline

Who this might be right for
Alzheimer Disease
Novartis Pharmaceuticals 1,584
Not applicableNot Yet RecruitingNCT06828289
What this trial is testing

Rivastigmine Mini-Tablet for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Peking University First Hospital 1,000
Not applicableEnded earlyNCT01143350
What this trial is testing

Non Pharmacological Treatment in Alzheimer's Disease and Associated Disorders

Who this might be right for
Alzheimer's Disease
Centre Hospitalier Universitaire de Nice 300
Not applicableLooking for participantsNCT06688968
What this trial is testing

Neuropsychological Profiles and Musical Engagement in Parkinson's and Alzheimer's Disease

Who this might be right for
Alzheimer Disease, Early OnsetParkinsons Disease with DementiaNon Pharmacological Intervention
University Hospital, Montpellier 120
Not applicableStudy completedNCT05077826
What this trial is testing

Enhancing Memory in Mild Cognitive Impairment and Early Stage Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
The Mind Research Network 98
Not applicableActive Not RecruitingNCT04055376
What this trial is testing

Daily Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseAlzheimer Dementia
Massachusetts Institute of Technology 15
Testing effectiveness (Phase 2)Study completedNCT01584440
What this trial is testing

Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease

Who this might be right for
AgitationAlzheimer's Disease
Avanir Pharmaceuticals 220
Large-scale testing (Phase 3)Looking for participantsNCT07170150
What this trial is testing

A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

Who this might be right for
Alzheimers Disease
Hoffmann-La Roche 800
Next Page